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The objective of this work was to evaluate the bioavailability of heme iron added to biscuit filling. It comprised 
two stages: first, the development of the heme iron enriched biscuit filling; second, the evaluation of the 
bioavailability of the mineral in fattening piglets. Two groups were selected randomly and fed: a) Low iron feed 
and biscuits with heme iron supplemented filling; b) Normal feed (with ferrous sulphate). Weight and blood 
parameters were measured every fifteen days. Averages were compared after duplicate analyses. The filling had 
a creamy appearance, chocolate taste and smell, appropriate spreadability, heme iron content of 2.6 mg per gram 
and a shelf-life of a month. The heme iron supplemented pigs registered a greater (P<0.05) weight gain (27.8% 
more than the control group). Mortality in the heme iron group was 10%, compared to 50% in the control group. 
The amount of iron measured in the different compartment was greater in the heme group (3315 mg) than in the 
control group (2792 mg). However, the amount of iron consumed in the latter was greater. We show that an 
acceptable product with high heme iron content can be formulated, suitable for use as biscuit filling. The heme 
iron supplement produced better weight increase and lesser mortality in fattening pigs. The bioavailability of 
heme iron was 23% greater (P<0.05) compared to ferrous sulphate. 
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INTRODUCTION 
Although pervasively widespread in the world, 
iron is the nutrient with a most pronounced deficiency 
in humans [1, 2] Many remedial actions have been 
undertaken; nevertheless, the problem persists for a 
number of reasons: unspecific diet supplements, poor 
dietary food combinations and low bioavailability in 
the iron-bearing products consumed [3-5] Dietary iron 
occurs in two forms: 1) non-heme iron; derived mainly 
from vegetable products, and 2) heme iron; only found 
in products of animal origin [5, 6]. Heme iron is more 
easily absorbed in the diet than inorganic iron; because 
the absorption process is different for each [7]. 
There are experiences on the use of bovine and 
pig blood to exploit their high nutritional value and 
coincidentally eliminate a highly polluting effluent [8]. 
These experiences show that a base product can 
be obtained with a high heme iron concentration and 
good bioavailability for direct consumption or food 
supplements [5, 9-11]. Satisfactory results have been 
obtained with the addition of heme derivatives to 
some foods. For example, in 1993 Walter et al [12], 
achieved this with biscuits; Pallares et al [13] added 
bovine blood to a cereal with milk; Aznar and 
González [14], developed a protein-mineral food 
supplement (TROFIN), using dried whole blood with 
hydrolyzed proteins as a base. 
Many techniques are available for studying iron 
bioavailability, which can be classified as: in vitro 
studies and live studies depending on the model used 
the latter in either animals or humans [6]. The in vitro 
studies are cheaper and permit a greater control over 
the experimental variables. The main limitation of 
these methods is that they cannot simulate 
physiological states or some physical and chemical 
properties and adaptive responses that influence the 
bioavailability of iron [15]. Although recent methods 
have been developed attempt to correct these 
limitations and approach the absorption conditions in 
the small intestine [16]. Absorption studies in humans 
continue to be the gold standard in estimating the 
bioavailability of iron; nevertheless, animals tests are 
often more practical for the prediction of nutrient 
bioavailability [6,17]. Int. J. Biol. Sci. 2008, 4 
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The pig is considered a model that shares more 
human structure and function similarities than other 
animals. More variables can be measured, such as 
those related to the diet or growth rate. For these 
reasons, was chosen as the model for this study [18]. 
The objective of this work was to evaluate the 
bioavailability of a heme iron concentrate product 
incorporated into a chocolate flavor biscuit filling. 
MATERIAL AND METHODS 
All analyses were performed by two replicates. 
Development of biscuit filling 
A previous study (data not shown) used a 
factor-by-factor procedure [19], to evaluate several 
ingredients and formulas (hydrocolloids among them); 
from this the definitive one was selected, consisting of 
9 ingredients (table 1). By means of the researchers’ 
direct observation and using an arbitrary scale (from 0 
to 5), the spreadability, flow, colour, smell, flavor, 
adhesion, gumminess, firmness, cutting effort and 
radiance characteristics were measured. 
Table 1. Formula of Heme iron enrichment filling 
Ingredients Inclusion  % 
Glucose 15.9 
Sugar 39.7 
Heme iron  17.9 
Simplesse-100 5.0 
Skimmed cocoa  5.0 
Cocoa flavor  4.5 
Titanium Dioxide  1.5 
Orange E-1101  0.5 
Water 10.0 
Total 100 
1 Colorant to 20%. 
Microbiological analyses 
Microbiological checks were applied during the 
process and to the end product, making measurements 
of total counts, enterobacteria, moulds and yeasts, 
Salmonella spp. and Escherichia coli. 
Working ingredient 
The heme iron used for the fortification is a dark 
colour dust, obtained from animal blood from healthy 
pigs that have passed veterinary inspections 
satisfactorily in registered slaughter houses and 
hygienically collected after the addition of an 
appropriate anticoagulant. After the separation of the 
corpuscular fraction by centrifuging, a pressure pump 
is used to liberate the hemoglobin contained in the 
erythrocytes. The hemoglobin is later enzymatically 
hydrolyzed by a proteolytic enzyme (Alcalase®; 
Novo-Nordisk. Denmark) working within its specific 
conditions (pH 8,5 and 50ºC). Afterwards, globin 
peptones were separated from the heme group 
enriched concentrate by ultrafiltration. 
Protein, fat, humidity and ash were analyzed 
following the methodology proposed in the AOAC 
[20]; iron and zinc were measured by Flame Atomic 
Absorption Photospectrometer in a PERKIN-ELMER 
Photospectrometer, 2100 model [21].   
Bioavailability evaluation 
The sample size calculation and the study itself 
was made with 20 common pigs (Sus scrofa domesticus), 
Belgian Pietrain; females, 4 weeks old, with an average 
weight of 7 Kg, that only received 100 mg of dextrane 
iron administration at birth with the intention of 
producing a slight iron deficiency at weaning. 
By means of random selection two groups of 10 
piglets each were formed: 
1. Study group. This group was fed a low iron 
diet (452.7 mg/Kg) and sandwich biscuits with a 
chocolate flavor filling with added heme iron. 
2. Control group. This group was fed normal 
food, which contained ferrous sulphate (537.1 mg/Kg). 
The iron supplement was given during 20 weeks, 
making daily inspections, taking their weight and 
blood samples every fortnight, applying antiparasitic 
treatment as required and a veterinary check-up 
monthly. 
The blood samples were extracted from the 
superior cave vein after the pigs were tranquilized 
with Azaperone (Stresnil®). 7 ml of blood was 
extracted, of which 3 ml was put in a tube with EDTA 
to make the red series analyses; the rest of the blood (4 
ml) was emptied into a tube with separating serum gel 
to make the biochemical analyses. The samples were 
transported from the farm to the laboratory 
refrigerated and they were immediately processed. 
The hematological measurements were made with an 
Advia (TM) 120 (Bayer Diagnostics Europe SL, [22], 
and the biochemical measurements with an COBAS 
MIRA 89 (ROCHE) Chemical Analyzing System, using 
the Ferrozine iron A11A00091 ABX commercial kit. 
The measurement of iron in the liver was made by 
atomic absorption spectrophotometer with 
PERKIN-ELMER equipment, model 2100, using a 
sample taken immediately after slaughtering and deep 
frozen to -20º C until the analysis 15 days later. 
This study was approved by the Autonomous 
University of Barcelona ethics commission. The 
end-point criteria for the experiment was either the 
existence of incapacitating or incurable disease or the 
completion of study (20 weeks); in both cases, 
slaughtering was done by administering sodium 
pentobarbital on the same pig farm [23,24].  
Statistical analysis 
The statistical analysis was done with the SPSS 
13.0 software. First, descriptive analysis was Int. J. Biol. Sci. 2008, 4 
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performed, using duplicate determination of initial 
and final values, and comparing independent averages 
of the results of both groups. 
RESULTS AND DISCUSSION 
Table 2 shows the composition of the filling 
formulated; it may be observed that heme contribution 
of iron is 2,6 mg for each gram of filling, so a single 
biscuit containing 5 grams of product will contribute 
u p  t o  1 3  m g  o f  i r o n ,  c o v e r i n g  1 0 0 %  o f  t h e  
recommended iron intake for humans [25]. The 14.1% 
protein content, being of hemoglobin and milk serum, 
is of high biological quality [26]. The product 
additionally contains small amounts of other nutrients 
of possible nutritional value. The filling obtained was 
directly observed to have a creamy appearance, 
chocolate smell and flavor and appropriate 
spreadability. 
Table 2. Chemical composition of enriched filling with Heme 
iron (100 g) 
Composition Quantity 
Proteins, g  14.1 
Fat, g  10.9 
Carbohydrates, g  65.2 
Ash, g   5.3 
Humidity, %  4.5 
Iron, mg  260.0 
Zinc, mg  0.8 
 
The bioavailability evaluation began with 20 
piglets, randomly separated into two groups. The 
expected values column [27] in table 3 gives some 
hematological reference parameters for piglets of 
similar ages and weights and, despite a relatively high 
variation coefficient, can be used as a guide to verify 
that the results obtained for most of the parameters 
studied were within the norm. We observed a high 
weight variation (variation coefficient 0.23), indicating 
a quite heterogeneous study group.  
Given the heterogeneousness of the group, care 
was exercised to ensure randomness in the separation 
into groups. Table 3 shows the characteristics of each. 
Some differences can be noted; nevertheless in all cases 
these were not statistically significant, therefore we can 
assume that the groups were not different and that the 
splitting process was satisfactory. 
Of the total number of pigs when the study 
began, 6 died during the trial, 5 from control group 
(50%) and 1 from heme group (10%). There was a risk 
that the pigs that died shared a common 
differentiating characteristic compared to the 
survivors, thereby slanting the results. However, 
comparing the values of variables of both groups, we 
observed that although there were slight differences in 
some variables they had no statistical significance, 
leading us to consider that there was no factor which 
influenced mortality differentially in the study groups, 
since both were subjected to the same treatment and 
therefore the same stress, probably the cause of the 
high mortality [28-30]. 
Table 3. Weight and hematological characteristics of piglets *, 
according to group and normality 
 






Heme Control   
Weight, kg  6.9 ± 1.7  6.9 ± 1.7  - 
Erythrocytes, 
106/μl  
6.5 (1.0)  6.00 (0.5)  5-7 
Hemoglobin, g/dl  11.5 (1.5)  11.7 (1.2)  9-13 
Hematocrite, %  34.1 (7.4)  32.5 (3.6)  36-43 
VCM, fl  52.6 (6.7)  54.3 (1.4)  52-62 
CMH, pgl  18.0 (3.2)  19.5 (1.9)  17-24 
CCMH, g/dl  34.3 (4.9)  36.0 (2.1)  29-34 
Seric iron, μ/dl 212.7 
(110.7) 
238.3 (84.4)  172±60 
Leucocytes, 103/μl  21.5 (6.8)  21.5 (3.1)  11-22 





Lymphocytes, %  47.7 (12.0)  60.2 (6.0)  35-75 
Monocytes, %  3.9 (2.3)  2.7 (1.3)  0-10 
Neutrophils, %  42.1 (18.6)  35.4 (7.2)  20-70 
Eosinophils, %  1.9 (0.8)  3.1 (0.5)  0-10 
* Expressed as average and standard deviation 
** No statistical differences were detected (p>0.05) 
- Not applied 
 
Figure 1 shows the behavior of both study 
groups’ weights; there was a slight not statistically 
significant difference between them from week 8 until 
week 13 (p>0,05); from which point the heme 
supplement group increasingly took off until the end 
of the study in week 20. Both groups started with an 
average weight of 6.9 (1.6) Kg; but the increase was 
much greater in the heme group, their final weight 
being 56.7 Kg, an increase of 49.8 Kg. In contrast, the 
control group, whose final weight average reached 
43.9 Kg, an increase of 37 Kg, giving a statistically 
significant (p<0.05) difference of 12.8 Kg between the 
groups, and agreeing with the results obtained by 
Perestrelo and Perestrelo [31], who used 
amino-quelated iron in their supplement and 
concluded that it reduces mortality and improved 
growth. 
On average, the heme group pigs consumed 10.5 
Kg of sandwich biscuits (498 pieces), a total of 46,737 
Kcal, which, when converted to animal weight at the 
rate of 9,200 Kcal per Kg [32], gives a total of 5.1 Kg of 
weight attributable to biscuit consumption. Therefore, 
the actual difference exclusively due to the heme iron 
source were 7.7 Kg (17.2%) in favor of the heme iron 
supplement group. 




Figure 1. Average of body weight of 20 piglets from 4 to 20 
weeks of age. 
 
 
Table 4 shows the iron measured in tissues and 
subsequently calculated for each tissue, as well as the 
sum of each and the percentage relative to the total 
iron consumed by the pigs throughout the study, 
according to the supplement group they belonged to. 
We can observe significant differences between the 
groups with respect to iron in the blood, but not in the 
other body parts, although the heme group showed 
values higher than the ferrous sulphate supplement 
group as regards both the liver and hemoglobin. The 
difference in absorption percentage between the 
groups was significant (P<0.05); the absorption of 
heme iron was shown to be 23% superior to ferrous 
sulphate.  
 
Table 4. Iron quantity in different compartments (average and standard deviation) and percentage of iron absorption in relation to 
iron consumed 







Total**  Ingested  
Heme iron  3,032 (636)  277 (131)  6,2 (1.6)  3,315 (689)  63,980 
Control 2,498  (723)  287 (45)  6.7 (1.7)  2,792 (754)  69,810 
5.2 (1.0) 
4.0 (1.0) 
* Statistically significant differences p< 0.05. 
** Statistically not significant differences. p>0.05.   
 
 
In conclusion, the adverse characteristics of heme 
iron (dark colour, blood smell and flavor) can be 
transformed and exploited by its incorporation into a 
suitable base, which in this case was a chocolate 
flavored biscuit filling. Mortality was less in the heme 
iron supplement group of pigs; the weight also was 
greater in this group and there was a clear difference in 
favor of the heme iron group in the total measured iron 
averages; although the heme group pigs consumed 
less iron; therefore, we can conclude that the measured 
bioavailability of heme iron was greater than that of 
ferrous sulphate. 
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